Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models
Multiple myeloma (MM) is the second most common hematological malignancy and is characterized by the clonal expansion of plasma cells in the bone marrow. Recently, hypoxia has received increased interest in the context of MM, in both basic and translational research. In this review, we describe the...
Main Authors: | Jinsong Hu, Els Van Valckenborgh, Eline Menu, Elke De Bruyne, Karin Vanderkerken |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2012-11-01
|
Series: | Disease Models & Mechanisms |
Online Access: | http://dmm.biologists.org/content/5/6/763 |
Similar Items
-
Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma
by: Elke De Bruyne, et al.
Published: (2013-04-01) -
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma
by: Kim De Veirman, et al.
Published: (2014-06-01) -
Histone deacetylase inhibitors in multiple myeloma
by: Sarah Deleu, et al.
Published: (2009-06-01) -
AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma
by: Siyang Yan, et al.
Published: (2019-11-01) -
Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?
by: Catharina Muylaert, et al.
Published: (2022-08-01)